Gene · 8013
Papers2,089
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,089
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mucoacinar Carcinoma of the Parotid Gland. | Head Neck Pathol | 2026 | 41636986 | PubTator, text mining | PubMed |
| Obesity Reprogrammes Adipose Extracellular Vesicles to Induce Muscle Atrophy via miR-150-5p-Mediated Transcriptional Silencing. | J Cachexia Sarcopenia Muscle | 2026 | 41631960 | PubTator, text mining | PubMed |
| Unleashing CAR-T potential in solid tumors: overcoming intrinsic and extrinsic hurdles to improve therapy. | Cancer Immunol Immunother | 2026 | 41591467 | PubTator, text mining | PubMed |
| A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancers. | ESMO Open | 2026 | 41547215 | PubTator, text mining | PubMed |
| Restoring NR4A3 function in neutrophils alleviates sepsis by limiting NF-κB-dependent NETs formation and organ damage. | Mol Immunol | 2026 | 41443148 | PubTator, text mining | PubMed |
| GREB1-rearranged uterine tumour shares a common DNA methylation signature with ESR1-rearranged UTROSCT. | Histopathology | 2026 | 41424301 | PubTator, text mining | PubMed |
| Gestational Melatonin Supplementation Attenuates Maternal Sleep Deprivation-Induced Steatohepatitis Susceptibility in Offspring. | Cell Prolif | 2026 | 41146589 | PubTator, text mining | PubMed |
| Clinical and magnetic resonance imaging features of soft tissue extraskeletal myxoid chondrosarcoma: A retrospective observational cohort study. | Skeletal Radiol | 2026 | 41074947 | PubTator, text mining | PubMed |
| Oncocytic salivary gland carcinomas. | Histol Histopathol | 2026 | 40746167 | PubTator, text mining | PubMed |
| Overview of exosomal non-coding RNAs in cardiovascular disease using high throughput sequencing. | Eur J Pharmacol | 2025 | 42640698 | PubTator, text mining | PubMed |
| Prolonged Loss of Oxidative Phosphorylation and Mitochondrial Mass Characterize CD66b+ Leukocytes from Patients with Sepsis. | bioRxiv | 2025 | 41446068 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Venom Diversity. | Toxins (Basel) | 2025 | 41441617 | PubTator, text mining | PubMed |
| CD9-positive tumor-associated macrophages promote renal cell carcinoma progression by activating the orphan nuclear receptor Nor1/Nr4a3. | Cancer Cell Int | 2025 | 41388297 | PubTator, text mining | PubMed |
| Novel HSPA8-NR4A2 rearrangement in extraskeletal myxoid chondrosarcoma: a sarcoma mimicker of neuroendocrine neoplasia. | Virchows Arch | 2025 | 41315062 | PubTator, text mining | PubMed |
| Blocking nuclear receptor Nr4a3 unlocks the senescence barrier to promote direct cardiac reprogramming. | Sci Adv | 2025 | 41237238 | PubTator, text mining | PubMed |
| Identification of potential oncogenic miRNA clusters with a special focus on miR-106b/25 cluster-regulated networks and their clinical utility in hepatocellular carcinoma. | Discov Oncol | 2025 | 41196528 | PubTator, text mining | PubMed |
| Emerging in Diabetic Cardiomyopathy: Molecular Pathways and Targets for Therapeutic Intervention. | Drug Dev Res | 2025 | 41183131 | PubTator, text mining | PubMed |
| Targeting PABPC1: A therapeutic strategy of natural Ganoderma meroterpenoid LZ22 against triple-negative breast cancer proliferation. | Pharmacol Res | 2025 | 41125141 | PubTator, text mining | PubMed |
| Enhanced FOS expression improves tumor clearance and resists exhaustion in NR4A3-deficient CAR T cells under chronic antigen exposure. | Sci Adv | 2025 | 41105771 | PubTator, text mining | PubMed |
| From pathogenesis to the patient's bedside: a comprehensive review of extraskeletal myxoid chondrosarcoma. | J Cancer Res Clin Oncol | 2025 | 41055792 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8013/papers?page=3